The Glucagon Like Peptide 1 Analogs Market is driven by growing prevalence of diabetes The Glucagon Like Peptide 1 (GLP-1) analogs market has seen significant growth in recent years. GLP-1 analogs are injectable drugs used to treat type 2 diabetes. They work by stimulating the production of insulin from the pancreas and suppressing glucagon secretion, thereby lowering blood sugar levels. Some key advantages of GLP-1 analogs include weight loss in patients, low risk of...
0 Compartilhamentos
128 Visualizações
0 Anterior